Department of Ophthalmology and Department of Neurology, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institutes of Brain Science, Zhongshan Hospital, Fudan University, Shanghai, China.
Department of Ophthalmology and Department of Neurology, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institutes of Brain Science, Zhongshan Hospital, Fudan University, Shanghai, China
Diabetes. 2021 May;70(5):1157-1169. doi: 10.2337/db20-0775. Epub 2021 Feb 11.
Recent evidence suggests that melanopsin-expressing intrinsically photosensitive retinal ganglion cells (ipRGCs), a neuronal class regulating nonimage forming (NIF) vision and generally thought to be injury resistant, are dysfunctional in certain neurodegenerative diseases. Although disrupted NIF visual functions have been reported in patients and animals with diabetes, it remains controversial whether ipRGCs exhibit remodeling during diabetes and if so, whether such remodeling is variable among ipRGC subtypes. Here, we demonstrate that survival, soma-dendritic profiles, and melanopsin-based functional activity of M1 ipRGCs were unaltered in streptozotocin-induced 3-month diabetic mice. Such resistance remained at 6 months after streptozotocin administration. In contrast, M2/M3 ipRGCs underwent significant remodeling in diabetic mice, manifested by enlarged somata and increased dendritic branching complexity. Consistent with the unaltered melanopsin levels, the sensitivity of melanopsin-based activity was unchanged in surviving M2 cells, but their response gain displayed a compensatory enhancement. Meanwhile, the pupillary light reflex, a NIF visual function controlled by M2 cells, was found to be impaired in diabetic animals. The resistance of M1 cells might be attributed to the adjacency of their dendrites to capillaries, which makes them less disturbed by the impaired retinal blood supply at the early stage of diabetes.
最近的证据表明,表达黑视蛋白的光感受器神经节细胞(ipRGCs),一类调节非成像(non-image forming,NIF)视觉的神经元,通常被认为具有抗损伤能力,在某些神经退行性疾病中功能失调。尽管糖尿病患者和动物的 NIF 视觉功能已经被破坏,但 ipRGCs 在糖尿病期间是否发生重塑,以及如果发生重塑,这种重塑在 ipRGC 亚型中是否存在差异,仍然存在争议。在这里,我们证明了在链脲佐菌素诱导的 3 个月糖尿病小鼠中,M1 ipRGCs 的存活、体树突形态和基于黑视蛋白的功能活性没有改变。在链脲佐菌素给药后 6 个月,这种抗性仍然存在。相比之下,M2/M3 ipRGCs 在糖尿病小鼠中经历了显著的重塑,表现为细胞体增大和树突分支复杂性增加。与黑视蛋白水平不变一致,存活的 M2 细胞中基于黑视蛋白的活性的敏感性没有改变,但它们的反应增益显示出代偿性增强。同时,发现由 M2 细胞控制的瞳孔光反射,一种 NIF 视觉功能,在糖尿病动物中受损。M1 细胞的抗性可能归因于它们的树突与毛细血管的相邻,这使得它们在糖尿病早期受到受损的视网膜血液供应的干扰较小。